In Brazil, increased leaf spot disease (Pyrenophora chaetomioides Speg.) frequency and intensity on cultivated spring oat (Avena sativa) requires that plant pathologists and breeders rapidly identify oat genotypes with greater resistance. Criteria are needed to compare and evaluate oat genotypes to screen large numbers of lines, quantification of resistance components under controlled conditions allowing year-long screening and the rejection of susceptible lines before lengthy field trials. There is a need to determine which resistance components are associated with leaf spot intensity in the field, as estimated from the area under the disease progress curve (AUDPC). We assessed various oat P. chaetomioides resistance components under controlled conditions in seedlings of 26 oat genotypes chosen from recommended varieties and elite breeding lines to determine the association of resistance components with the AUDPC, obtained by evaluating each genotype in the field. The resistance components estimated were: initial lesion size (ILS) and final lesion size (FLS); rate of lesion expansion (r); and area under the normalized and corrected lesion expansion curve (AULECc). All correlations were positive and significant at p00.01 and were distributed into moderate (0.5< r<0.8) and strong (0.8≤r<1) correlation classes. The strongest average correlations occurred with the AULECc (0.827), ILS (0.801) and FLS (0.801) components. These results indicate which components may be useful in resistance screening, with FLS possibly being the most useful criterion because it is less laborious to obtain and speeds up the selection process for leaf spot resistance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.